EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Results of a long‐term, prospective study on complications of central venous catheter in pediatric patients with hematologic‐oncologic diseases

Chiara Garonzi iD, Francesca Zeni, Gloria Tridello, Alice Giacomazzi, Alberto Castagna, Maria Pia Esposto, Giulia Caddeo, Vincenza Pezzella, Ada Zaccaron, Elisa Bonetti, Virginia Vitale, Matteo Chinello iD und 4 weitere

Pediatric Blood & Cancer · 2024-07 · 71 (7)

DOI: 10.1002/pbc.30990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 11.04.2024. Verfasst von Chiara Garonzi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, Dentistry, Pediatrics and Gynecology, University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Central Venous Catheters, Catheter-Related Infections, Catheterization, Central Venous, Hematologic Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Verona, Università degli Studi di Verona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Central venous catheter (CVC)‐related complications remain a significant cause of morbidity in pediatric hematology‐oncology. We prospectively surveyed the incidence of CVC‐related complications in children with hematologic‐oncologic diseases. Procedure Five‐hundred‐eighty‐one CVCs were inserted in 421 patients from January 2010 to June 2022 (153,731 CVC days observation; follow‐up data up to December 31, 2022).

Results

Overall, 671 complications were recorded (4.365/1000 CVC days): 49.7% malfunctions (1.88/1000 CVC days, 4.8% of CVC early removals), 23.9% bacteremia (0.90/1000, 15.1%), 19.6% mechanical complications (0.74/1000, 70.2%), 20.1% localized infections (0.76/1000, 17.1%), 0.5% thrombosis (0.02/1000, 33.3%). At multivariate analysis, risk factors for malfunction were Broviac–Hickman type of CVC (hazard ratio [HR] 2.5) or Port‐a‐cath (HR 3.4) or Proline (HR 4.3), p < .0001; for bacteremia double‐lumen CVC (HR 3.2, p < .0001); for mechanical complications age at CVC insertion under median (HR 4.5, p < .0001) and Broviac–Hickman (HR 1.6) or Proline (HR 2.7), p = .01; finally for localized infections Broviac–Hickman (HR 2.9) or Proline (HR 4.4), p = .0001. The 2‐year cumulative incidence of premature removal was 23.5%, and risk factors were age at CVC insertion under median (HR 2.4, p < .0001), Broviac–Hickman (HR 2.3) or Proline (HR 4.2), p < .0001.

Conclusions

Premature removal occurs in approximately 20%–25% of long‐term CVCs. A surveillance program has a fundamental role in identifying the risk factors for CVC complications and the areas of intervention to improve CVC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Venous CathetersCatheter-Related InfectionsCatheterization, Central VenousHematologic NeoplasmsHumansFemaleChildMaleProspective StudiesChild, PreschoolAdolescentInfantFollow-Up StudiesRisk FactorsBacteremiaIncidencePrognosis

Stichwörter der Autor:innen

central venous catheterchemotherapycomplicationspediatric malignancystem cell transplantation

Autor:innen und Institutionen

  • Department of Surgical Sciences, Dentistry, Pediatrics and Gynecology, University of Verona, Verona, Italy.
  • Pediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
  • Intensive Care and Anesthesia Unit, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.

ORCID-Profile: Chiara Garonzi, Matteo Chinello, Simone Cesaro

Förderung

  • University of Verona
  • Università degli Studi di Verona

Zitieren

APA

Garonzi, C., Zeni, F., Tridello, G., Giacomazzi, A., Castagna, A., Esposto, M. P., Caddeo, G., Pezzella, V., Zaccaron, A., Bonetti, E., Vitale, V., Chinello, M., Balter, R., Guardini, B., Pedrazzoli, E., & Cesaro, S. (2024). Results of a long‐term, prospective study on complications of central venous catheter in pediatric patients with hematologic‐oncologic diseases. Pediatric Blood & Cancer, 71(7). https://doi.org/10.1002/pbc.30990

Vancouver

Garonzi C, Zeni F, Tridello G, Giacomazzi A, Castagna A, Esposto MP, et al. Results of a long‐term, prospective study on complications of central venous catheter in pediatric patients with hematologic‐oncologic diseases. Pediatric Blood & Cancer. 2024;71(7). doi:10.1002/pbc.30990

BibTeX
@article{Garonzi2024,
  author = {Garonzi, Chiara and Zeni, Francesca and Tridello, Gloria and Giacomazzi, Alice and Castagna, Alberto and Esposto, Maria Pia and Caddeo, Giulia and Pezzella, Vincenza and Zaccaron, Ada and Bonetti, Elisa and Vitale, Virginia and Chinello, Matteo and Balter, Rita and Guardini, Beatrice and Pedrazzoli, Eleonora and Cesaro, Simone},
  title = {Results of a long‐term, prospective study on complications of central venous catheter in pediatric patients with hematologic‐oncologic diseases},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  volume = {71},
  number = {7},
  doi = {10.1002/pbc.30990}
}
Kostenlos starten →